Bio-reference Labs, Inc. (BRLI) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Join SI Premium – FREE
Bio-reference Labs, Inc. (NASDAQ: BRLI) reported Q4 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $151.3 million versus the consensus estimate of $150.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
